Sunitinib, Malate Salt 5g
To Order Contact us: lieven@wlsolutions.be
Sunitinib malate |
||
| A8255-1000 | 1 g | EUR 120 |
|
Description: Tyrosine Kinase|PDGFR#Tyrosine Kinase|VEGFR |
||
Sunitinib malate |
||
| A8255-2000 | 2 g | EUR 160 |
|
Description: Tyrosine Kinase|PDGFR#Tyrosine Kinase|VEGFR |
||
Sunitinib malate |
||
| A8255-5.1 | 10 mM (in 1mL DMSO) | EUR 44 |
|
Description: Tyrosine Kinase|PDGFR#Tyrosine Kinase|VEGFR |
||
Sunitinib malate |
||
| A8255-500 | 500 mg | EUR 80 |
|
Description: Tyrosine Kinase|PDGFR#Tyrosine Kinase|VEGFR |
||
Sunitinib malate |
||
| A8255-S | Evaluation Sample | EUR 24 |
|
Description: Tyrosine Kinase|PDGFR#Tyrosine Kinase|VEGFR |
||
Sunitinib malate |
||
| 100790 | 100.0mg | EUR 150 |
Sunitinib malate |
||
| abx076753-100l | 100 µl | EUR 131.25 |
Sunitinib malate |
||
| abx076753-1ml | 1 ml | Ask for price |
Sunitinib malate |
||
| abx076753-200l | 200 µl | EUR 237.5 |
Sunitinib malate |
||
| 20-abx076753 |
|
|
Sunitinib malate |
||
| GP2160 | 10mg | EUR 108.65 |
Sunitinib malate |
||
| GP2160-10 | 10 | EUR 47.4 |
Sunitinib malate |
||
| GP2160-100 | 100 | EUR 118.7 |
Sunitinib malate |
||
| GP2160-100MG | 100 mg | EUR 180 |
Sunitinib malate |
||
| GP2160-10MG | 10 mg | EUR 93.6 |
Sunitinib malate |
||
| GP2160-50 | 50 | EUR 71.1 |
Sunitinib malate |
||
| GP2160-50MG | 50 mg | EUR 122.4 |
Sunitinib (Malate) |
||
| HY-10255 | 100 mg | EUR 123.38 |
|
Description: Sunitinib Malate (SU 11248 Malate) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib Malate, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. |
||
Sunitinib Malate |
||
| MBS577938-100mg | 100mg | EUR 145 |
Sunitinib Malate |
||
| MBS577938-200mg | 200mg | EUR 155 |
Sunitinib Malate |
||
| MBS577938-25mg | 25mg | EUR 120 |
Sunitinib Malate |
||
| MBS577938-500mg | 500mg | EUR 165 |
Sunitinib Malate |
||
| MBS577938-50mg | 50mg | EUR 130 |
Sunitinib malate |
||
| MBS515034-25mg | 25mg | EUR 475 |
Sunitinib malate |
||
| MBS515034-5mg | 5mg | EUR 220 |
Sunitinib malate |
||
| MBS515034-5x25mg | 5x25mg | EUR 1875 |
Sunitinib Malate |
||
| MBS3604155-100mg | 100mg | EUR 200 |
Sunitinib Malate |
||
| MBS3604155-200mg | 200mg | EUR 215 |
Sunitinib Malate |
||
| MBS3604155-25mg | 25mg | EUR 185 |
Sunitinib Malate |
||
| MBS3604155-500mg | 500mg | EUR 225 |
Sunitinib Malate |
||
| MBS3604155-50mg | 50mg | EUR 195 |
Sunitinib Malate |
||
| MBS386230-100mg | 100mg | EUR 145 |
Sunitinib Malate |
||
| MBS386230-1mLinDMSO | 1mL(inDMSO) | EUR 140 |
Sunitinib Malate |
||
| MBS386230-200mg | 200mg | EUR 175 |
Sunitinib Malate |
||
| MBS386230-500mg | 500mg | EUR 195 |
Sunitinib Malate |
||
| MBS386230-50mg | 50mg | EUR 130 |
Sunitinib Malate |
||
| MBS6078588-10mg | 10(mg | EUR 445 |
Sunitinib Malate |
||
| MBS6078588-5x10mg | 5x10mg | EUR 1860 |
Sunitinib malate |
||
| MBS808181-25mg | 25mg | EUR 525 |
Sunitinib malate |
||
| MBS808181-5mg | 5mg | EUR 225 |
Sunitinib malate |
||
| MBS808181-5x25mg | 5x25mg | EUR 2120 |
Sunitinib malate |
||
| MBS808181-5x5mg | 5x5mg | EUR 765 |
Sunitinib malate |
||
| SIH-482-25MG | 25 mg | EUR 336.8 |
Sunitinib malate |
||
| SIH-482-5MG | 5 mg | EUR 80.8 |
Sunitinib Malate |
||
| T0374-10mg | 10mg | Ask for price |
|
Description: Sunitinib Malate |
||
Sunitinib Malate |
||
| T0374-1g | 1g | Ask for price |
|
Description: Sunitinib Malate |
||
Sunitinib Malate |
||
| T0374-1mg | 1mg | Ask for price |
|
Description: Sunitinib Malate |
||
Sunitinib Malate |
||
| T0374-50mg | 50mg | Ask for price |
|
Description: Sunitinib Malate |
||
Sunitinib Malate |
||
| T0374-5mg | 5mg | Ask for price |
|
Description: Sunitinib Malate |
||
Sunitinib Malate (Sutent) |
||
| 1611-100 | each | EUR 248.4 |
Sunitinib Malate (Sutent) |
||
| 1611-1000 | each | EUR 614.4 |
Sunitinib Malate (Sutent) |
||
| 1611-25 | each | EUR 151.2 |
Sunitinib malate SU11248) |
||
| MBS132027-100mg | 100mg | EUR 1065 |
Sunitinib malate SU11248) |
||
| MBS132027-500mg | 500mg | EUR 2775 |
EZSolution? Sunitinib Malate |
||
| 1804-25 | each | EUR 164.4 |
KRIBIOLISA Sunitinib Malate (SUTENT) ELISA |
||
| KOD1019 | 1 x 96 wells | EUR 1067 |
Sunitinib Maleate (Sutent, Sunitinib Malate, SU-11248, PHA-290940AD, PNU-290940AD) |
||
| MBS6114927-100mg | 100(mg | EUR 215 |
Sunitinib Maleate (Sutent, Sunitinib Malate, SU-11248, PHA-290940AD, PNU-290940AD) |
||
| MBS6114927-250mg | 250mg | EUR 310 |
Sunitinib Maleate (Sutent, Sunitinib Malate, SU-11248, PHA-290940AD, PNU-290940AD) |
||
| MBS6114927-500mg | 500mg | EUR 415 |
Sunitinib Maleate (Sutent, Sunitinib Malate, SU-11248, PHA-290940AD, PNU-290940AD) |
||
| MBS6114927-5x500mg | 5x500mg | EUR 1710 |
Sunitinib |
||
| B1045-100 | 100 mg | EUR 40 |
|
Description: Tyrosine Kinase|PDGFR |
||
Sunitinib |
||
| B1045-1000 | 1 g | EUR 120 |
|
Description: Tyrosine Kinase|PDGFR |
||
Sunitinib |
||
| B1045-2000 | 2 g | EUR 160 |
|
Description: Tyrosine Kinase|PDGFR |
||
Sunitinib |
||
| B1045-5.1 | 10 mM (in 1mL DMSO) | EUR 44 |
|
Description: Tyrosine Kinase|PDGFR |
||
Sunitinib |
||
| B1045-500 | 500 mg | EUR 80 |
|
Description: Tyrosine Kinase|PDGFR |
||
Sunitinib |
||
| HY-10255A | 200mg | EUR 135.28 |
|
Description: Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. |
||
Sunitinib |
||
| MBS577014-100mg | 100mg | EUR 145 |
Sunitinib |
||
| MBS577014-200mg | 200mg | EUR 165 |
Sunitinib |
||
| MBS577014-500mg | 500mg | EUR 180 |
Sunitinib |
||
| MBS577014-5x500mg | 5x500mg | EUR 655 |
Sunitinib |
||
| MBS3605026-100mg | 100mg | EUR 210 |
Sunitinib |
||
| MBS3605026-200mg | 200mg | EUR 225 |
Sunitinib |
||
| MBS3605026-5x200mg | 5x200mg | EUR 705 |
Sunitinib |
||
| MBS3842541-100mg | 100mg | EUR 140 |
Sunitinib |
||
| MBS3842541-500mg | 500mg | EUR 250 |
Sunitinib |
||
| MBS3842541-5x500mg | 5x500mg | EUR 1110 |
Sunitinib |
||
| T0374L-10mg | 10mg | Ask for price |
|
Description: Sunitinib |
||
Sunitinib |
||
| T0374L-1g | 1g | Ask for price |
|
Description: Sunitinib |
||
Sunitinib |
||
| T0374L-1mg | 1mg | Ask for price |
|
Description: Sunitinib |
||
Sunitinib |
||
| T0374L-50mg | 50mg | Ask for price |
|
Description: Sunitinib |
||
Sunitinib |
||
| T0374L-5mg | 5mg | Ask for price |
|
Description: Sunitinib |
||
Sunitinib-D4 |
||
| 20-abx184388 |
|
|
Sunitinib-d4 |
||
| HY-10255AS1 | 1 mg | EUR 643.95 |
|
Description: Sunitinib-d4 is the deuterium labeled Sunitinib. Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. |
||
Sunitinib-d4 |
||
| S820003 | 1mg | EUR 3524 |
|
Description: 1126721-79-6 |
||
Sunitinib-d10 |
||
| HY-10255AS | 1 mg | EUR 746.76 |
|
Description: Sunitinib-d10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. |
||